CardioTech Announces Conference Call on August 13 at 2:30 PM Eastern For First Quarter of Fiscal 2009

WILMINGTON, Mass.--(BUSINESS WIRE)--CardioTech International, Inc. (AMEX: CTE), a leading developer and manufacturer of advanced biomaterials for a broad range of medical devices, announced today that it will release its results for the first quarter of fiscal 2009 before the market opens on Wednesday, August 13, 2008. Following the release, the Company will host a conference call for investors at 2:30 p.m. ET (11:30 a.m. PT) to discuss its fiscal first quarter results as well as recent developments.

Participants should dial-in (866) 818-1223 Conference ID# 1266354 or (703) 639-1376 outside the U.S. Please dial-in 10 minutes before the call is scheduled to begin. A replay of the call will be available for two weeks following the call at (888)-266-2081 ID# 1266354 and on the Company’s website.

About CardioTech International:

Through its newly formed AdvanSource Biomaterials Corporation subsidiary, CardioTech develops advanced polymer materials which provide critical characteristics in the design and development of medical devices. The Company’s biomaterials are used in devices that are designed for treating a broad range of disease states and anatomical site. The Company’s business model leverages its proprietary materials science technology and manufacturing expertise in order to expand its product sales and royalty and license fee income. CardioTech is conducting a clinical trial for regulatory approval in Europe for its CardioPass™ synthetic coronary bypass graft. More information about CardioTech is available at its website: www.advbiomaterials.com.

CardioTech International, Inc.
Eric Walters, 978-657-0075
Vice President & Chief Financial Officer
info@advbiomaterials.com
or
VMW Corporate & Investor Relations
Sylvia Dresner, 212-616-6161
Senior Vice President
info@vmwcom.com